Riverbridge Partners LLC Cuts Stock Holdings in Option Care Health, Inc. $OPCH

Riverbridge Partners LLC cut its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 12.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,262,553 shares of the company’s stock after selling 184,403 shares during the period. Riverbridge Partners LLC’s holdings in Option Care Health were worth $40,225,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the stock. Cornerstone Planning Group LLC raised its position in Option Care Health by 7,621.4% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock valued at $30,000 after purchasing an additional 1,067 shares in the last quarter. Advisory Services Network LLC purchased a new stake in shares of Option Care Health during the third quarter worth approximately $35,000. McIlrath & Eck LLC purchased a new stake in shares of Option Care Health during the second quarter worth approximately $37,000. Caitong International Asset Management Co. Ltd acquired a new stake in Option Care Health in the third quarter valued at approximately $38,000. Finally, Hantz Financial Services Inc. raised its holdings in Option Care Health by 987.7% in the third quarter. Hantz Financial Services Inc. now owns 1,414 shares of the company’s stock valued at $39,000 after acquiring an additional 1,284 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Analysts Set New Price Targets

Several research firms have commented on OPCH. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Option Care Health from $31.00 to $36.00 and gave the stock a “buy” rating in a report on Tuesday, December 9th. Morgan Stanley increased their price target on shares of Option Care Health from $35.00 to $38.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 13th. Truist Financial set a $40.00 price objective on shares of Option Care Health in a research note on Tuesday, January 13th. Jefferies Financial Group reiterated a “buy” rating and set a $37.00 target price on shares of Option Care Health in a research note on Tuesday, January 13th. Finally, Barrington Research raised their price target on Option Care Health from $38.00 to $42.00 and gave the stock an “outperform” rating in a report on Friday, January 16th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $37.27.

Option Care Health Price Performance

Option Care Health stock opened at $27.75 on Friday. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.53 and a quick ratio of 0.96. The business has a 50 day simple moving average of $32.77 and a 200-day simple moving average of $30.72. Option Care Health, Inc. has a 12 month low of $24.24 and a 12 month high of $36.80. The stock has a market capitalization of $4.34 billion, a PE ratio of 21.68, a price-to-earnings-growth ratio of 1.60 and a beta of 0.85.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Tuesday, February 24th. The company reported $0.46 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.46. The firm had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.46 billion. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. Option Care Health’s quarterly revenue was up 8.8% on a year-over-year basis. During the same period last year, the firm posted $0.44 EPS. Equities analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.